Source comparison
Melanotan-1 Results After 1 Month: Clinical vs Anecdotal Comparison
Visible pigmentation change 2–3 Fitzpatrick shades at 4 weeks (controlled study conditions) '5+ shades darker' or 'no change at all' (highly variable self-assessment) 2–3 shades measurably darker than baseline with consistent dosing Expect moderate darkening.
This comparison does not assign a generated winner or score.
- Visible pigmentation change
- 2–3 Fitzpatrick shades at 4 weeks (controlled study conditions)
- '5+ shades darker' or 'no change at all' (highly variable self-assessment)
- 2–3 shades measurably darker than baseline with consistent dosing
- Expect moderate darkening. Not dramatic transformation. Peak occurs weeks 5–6.
- Time to first noticeable change
- 14–21 days (clinical observation)
- '3 days' to '6 weeks' (user variability in perception and dosing adherence)
- 10–16 days for existing pigmented areas; 18–24 days for generalised darkening
- Early changes occur in areas with pre-existing melanin density (freckles, areolae).
- Side effects
- Mild injection site reaction (15%), transient nausea (5–8%) per EMA data
- 'No side effects' to 'extreme nausea and libido increase' (suggests MT-2 contamination)
- Injection site erythema and occasional mild headache. Systemic effects rare
- MT-1 is well-tolerated. Reports of systemic effects indicate product contamination.
- UV dependence
- None. Designed for EPP patients avoiding sunlight entirely
- 'Doesn't work without tanning beds' (widespread misconception)
- Functions independently of UV exposure, though ambient sun may accelerate visibility
- UV is not required. Melanogenesis proceeds via MC1R signalling alone.
- Maintenance dosing after loading
- 1mg weekly or biweekly sustains pigmentation for months
- 'Daily dosing required' or 'stopped after 2 weeks' (poor protocol adherence)
- Weekly 1mg maintains melanin levels indefinitely after 4–6 week loading phase
- Loading builds density; maintenance sustains it. Stopping prematurely loses gains.